Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers, Anticancer Res, vol.23, pp.1883-90, 2003. ,
Tumour-associated transcripts and EGFR deletion variants in colorectal cancer in primary tumour, metastases and circulating tumour cells, Cell Oncol, vol.30, pp.463-71, 2008. ,
Measurements of EGFR expression on circulating tumor cells are reproducible over time in metastatic breast cancer patients, Pharmacogenomics, vol.10, issue.1, pp.51-58, 2009. ,
DOI : 10.2217/14622416.10.1.51
Anti-EGFR-Targeted Therapy for Esophageal and Gastric Cancers: An Evolving Concept, Journal of Oncology, vol.37, issue.13, p.804108, 2009. ,
DOI : 10.1158/1078-0432.CCR-05-0422
URL : http://doi.org/10.1155/2009/804108
Isolation and Characterization of Circulating Tumor Cells from Patients with Localized and Metastatic Prostate Cancer, Science Translational Medicine, vol.2, issue.25, pp.25-48, 2010. ,
DOI : 10.1126/scitranslmed.3000403
Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients, Breast Cancer Research and Treatment, vol.12, issue.3, pp.523-553, 2009. ,
DOI : 10.1007/s10549-009-0461-7
URL : https://hal.archives-ouvertes.fr/hal-00535380
Isolation of breast cancer and gastric cancer circulating tumor cells by use of an anti HER2-based microfluidic device, Lab Chip, vol.16, issue.1, pp.147-56, 2104. ,
DOI : 10.1039/C3LC51039E
MUC1-positive circulating tumor cells and MUC1 protein predict chemotherapeutic efficacy in the treatment of metastatic breast cancer, Chinese Journal of Cancer, vol.30, issue.1, pp.54-61, 2011. ,
DOI : 10.5732/cjc.010.10239
Molecular detection of blood-borne epithelial cells in colorectal cancer patients and in patients with benign bowel disease, International Journal of Cancer, vol.54, issue.1, pp.8-13, 2000. ,
DOI : 10.1002/(SICI)1097-0215(20000120)89:1<8::AID-IJC2>3.0.CO;2-K
Multigene Reverse Transcription-PCR Profiling of Circulating Tumor Cells in Hormone-Refractory Prostate Cancer, Clinical Chemistry, vol.50, issue.5, pp.826-861, 2004. ,
DOI : 10.1373/clinchem.2003.028563
Long term survival following the detection of circulating tumour cells in head and neck squamous cell carcinoma, BMC Cancer, vol.7, issue.1, p.424, 2009. ,
DOI : 10.2174/156800907782418365
Identification of circulating tumour cells in early stage breast cancer patients using multi marker immunobead RT-PCR, Journal of Hematology & Oncology, vol.2, issue.1 ,
DOI : 10.1186/1756-8722-2-24
Circulating tumour cells: their utility in cancer management and predicting outcomes, Therapeutic Advances in Medical Oncology, vol.2, issue.6, pp.351-65, 2010. ,
DOI : 10.1177/1758834010378414
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3126032
Potential Applications for Circulating Tumor Cells Expressing the Insulin-Like Growth Factor-I Receptor, Clinical Cancer Research, vol.13, issue.12, pp.3611-3617, 2007. ,
DOI : 10.1158/1078-0432.CCR-07-0268
Circulating Tumor Cells from Patients with Advanced Prostate and Breast Cancer Display Both Epithelial and Mesenchymal Markers, Molecular Cancer Research, vol.9, issue.8, pp.997-1007, 2011. ,
DOI : 10.1158/1541-7786.MCR-10-0490
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3157566
Universal Marker and Detection Tool for Human Sarcoma Circulating Tumor Cells, Cancer Research, vol.74, issue.6, pp.1645-50, 2014. ,
DOI : 10.1158/0008-5472.CAN-13-1739
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3959622